Skip to content
10-Q

Quarterly Report

Rocket Pharmaceuticals, Inc. RCKT RCKTW

0001193125-25-269474

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 108.22M sh
Shares Diluted Q3 2025 · Sep 30, 2025 111.57M sh
Shares Diluted Q3 2025 · Sep 30, 2025 110.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 94.16M sh
Shares Diluted Q3 2025 · Sep 30, 2024 93.89M sh
Capex Q3 2025 · Sep 30, 2025 $360K
Capex Q3 2025 · Sep 30, 2024 $5.55M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$155.17M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$162.78M
Short Term Investments Q3 2025 · Sep 30, 2025 $146.81M
Short Term Investments Q3 2025 · Dec 31, 2024 $208.7M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $75.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $163.64M
Stockholders Equity Q3 2025 · Sep 30, 2025 $313.67M
Stockholders Equity Q3 2025 · Jun 30, 2025 $354.21M
Stockholders Equity Q3 2025 · Mar 31, 2025 $412.14M
Stockholders Equity Q3 2025 · Dec 31, 2024 $463.23M
Stockholders Equity Q3 2025 · Sep 30, 2024 $329.77M
Stockholders Equity Q3 2025 · Jun 30, 2024 $384.64M
Stockholders Equity Q3 2025 · Mar 31, 2024 $441.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 $492.57M
Current Liabilities Q3 2025 · Sep 30, 2025 $31.17M
Current Liabilities Q3 2025 · Dec 31, 2024 $40.68M
Total Liabilities Q3 2025 · Sep 30, 2025 $54.36M
Total Liabilities Q3 2025 · Dec 31, 2024 $64.47M
Current Assets Q3 2025 · Sep 30, 2025 $227.68M
Current Assets Q3 2025 · Dec 31, 2024 $378.18M
Total Assets Q3 2025 · Sep 30, 2025 $368.03M
Total Assets Q3 2025 · Dec 31, 2024 $527.7M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.71
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.11
Eps Basic Q3 2025 · Sep 30, 2025 −$0.45
Eps Basic Q3 2025 · Sep 30, 2025 −$1.63
Eps Basic Q3 2025 · Sep 30, 2024 −$0.71
Eps Basic Q3 2025 · Sep 30, 2024 −$2.11
Sga Expense Q3 2025 · Sep 30, 2025 $18.35M
Sga Expense Q3 2025 · Sep 30, 2025 $71.82M
Sga Expense Q3 2025 · Sep 30, 2024 $27.11M
Sga Expense Q3 2025 · Sep 30, 2024 $76.62M
Rd Expense Q3 2025 · Sep 30, 2025 $34.07M
Rd Expense Q3 2025 · Sep 30, 2025 $112.67M
Rd Expense Q3 2025 · Sep 30, 2024 $42.32M
Rd Expense Q3 2025 · Sep 30, 2024 $133.89M
Net Income Q3 2025 · Sep 30, 2025 −$50.33M
Net Income Q3 2025 · Sep 30, 2025 −$180.59M
Net Income Q3 2025 · Jun 30, 2025 −$68.92M
Net Income Q3 2025 · Mar 31, 2025 −$61.33M
Net Income Q3 2025 · Sep 30, 2024 −$66.72M
Net Income Q3 2025 · Sep 30, 2024 −$198.42M
Net Income Q3 2025 · Jun 30, 2024 −$69.65M
Net Income Q3 2025 · Mar 31, 2024 −$62.05M
Operating Income Q3 2025 · Sep 30, 2025 −$52.25M
Operating Income Q3 2025 · Sep 30, 2025 −$187.78M
Operating Income Q3 2025 · Sep 30, 2024 −$69.42M
Operating Income Q3 2025 · Sep 30, 2024 −$210.51M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $0